Denevault-Sabourin C - Search Results

1

Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1.

Moine E, Dimier-Poisson I, Enguehard-Gueiffier C, Logé C, Pénichon M, Moiré N, Delehouzé C, Foll-Josselin B, Ruchaud S, Bach S, Gueiffier A, Debierre-Grockiego F, Denevault-Sabourin C. Moine E, et al. Eur J Med Chem. 2015 Nov 13;105:80-105. doi: 10.1016/j.ejmech.2015.10.004. Epub 2015 Oct 9. Eur J Med Chem. 2015. PMID: 26479029

2

A small-molecule cell-based screen led to the identification of biphenylimidazoazines with highly potent and broad-spectrum anti-apicomplexan activity.

Moine E, Denevault-Sabourin C, Debierre-Grockiego F, Silpa L, Gorgette O, Barale JC, Jacquiet P, Brossier F, Gueiffier A, Dimier-Poisson I, Enguehard-Gueiffier C. Moine E, et al. Eur J Med Chem. 2015 Jan 7;89:386-400. doi: 10.1016/j.ejmech.2014.10.057. Epub 2014 Oct 22. Eur J Med Chem. 2015. PMID: 25462254

3

Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis.

Moine E, Moiré N, Dimier-Poisson I, Brunet K, Couet W, Colas C, Van Langendonck N, Enguehard-Gueiffier C, Gueiffier A, Héraut B, Denevault-Sabourin C, Debierre-Grockiego F. Moine E, et al. Int J Parasitol. 2018 Jun;48(7):561-568. doi: 10.1016/j.ijpara.2017.12.006. Epub 2018 Mar 7. Int J Parasitol. 2018. PMID: 29524527

4

Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitors.

Oyallon B, Brachet-Botineau M, Logé C, Bonnet P, Souab M, Robert T, Ruchaud S, Bach S, Berthelot P, Gouilleux F, Viaud-Massuard MC, Denevault-Sabourin C. Oyallon B, et al. Eur J Med Chem. 2018 Jun 25;154:101-109. doi: 10.1016/j.ejmech.2018.04.056. Epub 2018 May 11. Eur J Med Chem. 2018. PMID: 29778892

5

A Novel Calcium-Dependent Protein Kinase 1 Inhibitor Potently Prevents Toxoplasma gondii Transmission to Foetuses in Mouse.

Débare H, Moiré N, Baron F, Lantier L, Héraut B, Van Langendonck N, Denevault-Sabourin C, Dimier-Poisson I, Debierre-Grockiego F. Débare H, et al. Among authors: denevault sabourin c. Molecules. 2021 Jul 10;26(14):4203. doi: 10.3390/molecules26144203. Molecules. 2021. PMID: 34299478 Free PMC article.

6

New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation.

Oyallon B, Brachet-Botineau M, Logé C, Robert T, Bach S, Ibrahim S, Raoul W, Croix C, Berthelot P, Guillon J, Pinaud N, Gouilleux F, Viaud-Massuard MC, Denevault-Sabourin C. Oyallon B, et al. Molecules. 2021 Feb 6;26(4):867. doi: 10.3390/molecules26040867. Molecules. 2021. PMID: 33562106 Free PMC article.

7

Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases.

Dao VH, Ourliac-Garnier I, Logé C, McCarthy FO, Bach S, da Silva TG, Denevault-Sabourin C, Thiéfaine J, Baratte B, Robert T, Gouilleux F, Brachet-Botineau M, Bazin MA, Marchand P. Dao VH, et al. Among authors: denevault sabourin c. Molecules. 2021 Oct 30;26(21):6572. doi: 10.3390/molecules26216572. Molecules. 2021. PMID: 34770981 Free PMC article.

8

Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate.

Mohamed Amar IA, Huvelle S, Douez E, Letast S, Henrion S, Viaud-Massuard MC, Aubrey N, Allard-Vannier E, Joubert N, Denevault-Sabourin C. Mohamed Amar IA, et al. Among authors: denevault sabourin c. Eur J Med Chem. 2022 Feb 5;229:114063. doi: 10.1016/j.ejmech.2021.114063. Epub 2021 Dec 24. Eur J Med Chem. 2022. PMID: 34974337

9

Towards antibody-drug conjugates and prodrug strategies with extracellular stimuli-responsive drug delivery in the tumor microenvironment for cancer therapy.

Joubert N, Denevault-Sabourin C, Bryden F, Viaud-Massuard MC. Joubert N, et al. Eur J Med Chem. 2017 Dec 15;142:393-415. doi: 10.1016/j.ejmech.2017.08.049. Epub 2017 Aug 23. Eur J Med Chem. 2017. PMID: 28911823 Review.

10

Design, synthesis, and antiproliferative effect of 2,9-bis[4-(pyridinylalkylaminomethyl)phenyl]-1,10-phenanthroline derivatives on human leukemic cells by targeting G-quadruplex.

Guillon J, Denevault-Sabourin C, Chevret E, Brachet-Botineau M, Milano V, Guédin-Beaurepaire A, Moreau S, Ronga L, Savrimoutou S, Rubio S, Ferrer J, Lamarche J, Mergny JL, Viaud-Massuard MC, Ranz M, Largy E, Gabelica V, Rosu F, Gouilleux F, Desplat V. Guillon J, et al. Among authors: denevault sabourin c. Arch Pharm (Weinheim). 2021 Aug;354(8):e2000450. doi: 10.1002/ardp.202000450. Epub 2021 Apr 14. Arch Pharm (Weinheim). 2021. PMID: 33852185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters